|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010802,
umls-concept:C0023467,
umls-concept:C0085862,
umls-concept:C0220901,
umls-concept:C0334044,
umls-concept:C0348080,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0600558,
umls-concept:C0936012,
umls-concept:C1274040,
umls-concept:C1299583,
umls-concept:C1515568,
umls-concept:C1521808,
umls-concept:C1549571,
umls-concept:C1552599,
umls-concept:C1556085,
umls-concept:C1608386,
umls-concept:C1704787,
umls-concept:C2347946,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-14
|
|
pubmed:abstractText |
On the basis of cytomorphology according to the French-American-British (FAB) classification, we evaluated the prognostic impact of dysplastic features and other parameters in de novo acute myeloid leukemia (AML). We also assessed the clinical significance of the recently introduced World Health Organization (WHO) classification for AML, which proposed dysplasia as a new parameter for classification.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AulCarloC,
pubmed-author:BüchnerThomasT,
pubmed-author:BalleisenLeopoldL,
pubmed-author:EimermacherHartmutH,
pubmed-author:FonatschChristaC,
pubmed-author:GassmannWinfriedW,
pubmed-author:GrüneisenAndreasA,
pubmed-author:HaaseDetlefD,
pubmed-author:HaferlachTorstenT,
pubmed-author:HeineckeAchimA,
pubmed-author:HiddemannWolfgangW,
pubmed-author:KarowJochenJ,
pubmed-author:KernWolfgangW,
pubmed-author:KubicaUschiU,
pubmed-author:LöfflerHelmutH,
pubmed-author:LengfelderEvaE,
pubmed-author:LudwigWolf-DieterWD,
pubmed-author:ReichleAlbrechtA,
pubmed-author:SauerlandMaria CristinaMC,
pubmed-author:SchlegelbergerBrigitteB,
pubmed-author:SchnittgerSusanneS,
pubmed-author:SchochClaudiaC,
pubmed-author:StaibPeterP,
pubmed-author:WörmannBernhardB,
pubmed-author:WuchterChristianC
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
256-65
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12525517-Acute Disease,
pubmed-meshheading:12525517-Adolescent,
pubmed-meshheading:12525517-Adult,
pubmed-meshheading:12525517-Aged,
pubmed-meshheading:12525517-Aged, 80 and over,
pubmed-meshheading:12525517-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12525517-Bone Marrow,
pubmed-meshheading:12525517-Chromosome Aberrations,
pubmed-meshheading:12525517-Cytogenetic Analysis,
pubmed-meshheading:12525517-Female,
pubmed-meshheading:12525517-Humans,
pubmed-meshheading:12525517-Immunophenotyping,
pubmed-meshheading:12525517-Karyotyping,
pubmed-meshheading:12525517-L-Lactate Dehydrogenase,
pubmed-meshheading:12525517-Leukemia, Myeloid,
pubmed-meshheading:12525517-Male,
pubmed-meshheading:12525517-Middle Aged,
pubmed-meshheading:12525517-Prognosis,
pubmed-meshheading:12525517-Prospective Studies,
pubmed-meshheading:12525517-Remission Induction,
pubmed-meshheading:12525517-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
|
|
pubmed:affiliation |
Department of Medicine III, Ludwig-Maximilians-University, Grosshadern, Munich, Germany. torsten.haferlach@med3.med.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
